GSK CEO says team reorg could be in the cards pending upcoming Phase 3 readouts
GSK CEO says team reorg could be in the cards pending upcoming Phase 3 readouts
GSK CEO says team reorg could be in the cards pending upcoming Phase 3 readouts
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.